Table 2 Percent of Patients with Scleritis and Systemic Condition
From: Health system wide “big data” analysis of rheumatologic conditions and scleritis
Condition | N | Scleritis cases | % of scleritis cases | % of disease with scleritis |
|---|---|---|---|---|
Total | 5,917,914 | 2702 | 31.4% | 0.05% |
RA | 19,923 | 184 | 6.8% | 0.9% |
HLA-B27 | 26,680 | 153 | 5.7% | 0.6% |
Sjogren | 10,576 | 121 | 4.5% | 1.1% |
Gout | 47,712 | 95 | 3.5% | 0.2% |
Lupus | 11,696 | 80 | 3.0% | 0.7% |
GPA | 859 | 45 | 1.7% | 5.2% |
Sarcoid | 7699 | 40 | 1.5% | 0.5% |
MS | 9980 | 30 | 1.1% | 0.3% |
PMR/GCA | 4456 | 29 | 1.1% | 0.7% |
MCTD | 4061 | 27 | 1.0% | 0.7% |
Scleroderma | 4232 | 17 | 0.6% | 0.6% |
PAN | 365 | 11 | 0.4% | 3.0% |
Behcet | 317 | 7 | 0.3% | 2.2% |
JIA/JRA | 1351 (23 HLA-B27+) | 9 (0 HLA-B27+) | 0.3% | 0.7% |